Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert-Jan Boons

Showing results (311-320 of 332) with videos related to

Pageof 34
Sort By:
Plos One|January 21, 2016
MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic MiceVani Lakshminarayanan, Nitin T Supekar, Jie Wei, et al.
Journal of Virology|January 19, 2022
<i>N</i>-Glycolylneuraminic Acid Binding of Avian and Equine H7 Influenza A VirusesCindy M Spruit, Xueyong Zhu, Ilhan Tomris, et al.
Veterinary Research|February 15, 2022
Pathobiology of highly pathogenic H5 avian influenza viruses in naturally infected Galliformes and Anseriformes in France during winter 2015-2016Nicolas Gaide, Marie-Noëlle Lucas, Mattias Delpont, et al.
Virus Evolution|May 29, 2024
Long-term evolution of human seasonal influenza virus A(H3N2) is associated with an increase in polymerase complex activityRené M Vigeveno, Alvin X Han, Robert P de Vries, et al.
Nature Communications|April 6, 2024
Probing altered receptor specificities of antigenically drifting human H3N2 viruses by chemoenzymatic synthesis, NMR, and modelingLuca Unione, Augustinus N A Ammerlaan, Gerlof P Bosman, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A long-chain heparan sulfate capture mechanism directs paracrine GDNF-GFRα1 signalling through RETMia I Zol-Hanlon, Beatrice Rix, Salomé Bodet-Lefèvre, et al.
Science Advances|December 22, 2021
Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfatesRichard Karlsson, Pradeep Chopra, Apoorva Joshi, et al.
Cell Host & Microbe|June 18, 2024
H19 influenza A virus exhibits species-specific MHC class II receptor usageUmut Karakus, Ignacio Mena, Jithesh Kottur, et al.
Blood Advances|July 2, 2020
Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicityA J Gerard Jansen, Thom Spaan, Hui Zhi Low, et al.
Cell Reports|June 13, 2019
N-Glycolylneuraminic Acid as a Receptor for Influenza A VirusesFrederik Broszeit, Netanel Tzarum, Xueyong Zhu, et al.
Pageof 34

Showing results (311-320 of 332) with videos related to

Sort By:
Pageof 34
Plos One|January 21, 2016
MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic MiceVani Lakshminarayanan, Nitin T Supekar, Jie Wei, et al.
Journal of Virology|January 19, 2022
<i>N</i>-Glycolylneuraminic Acid Binding of Avian and Equine H7 Influenza A VirusesCindy M Spruit, Xueyong Zhu, Ilhan Tomris, et al.
Veterinary Research|February 15, 2022
Pathobiology of highly pathogenic H5 avian influenza viruses in naturally infected Galliformes and Anseriformes in France during winter 2015-2016Nicolas Gaide, Marie-Noëlle Lucas, Mattias Delpont, et al.
Virus Evolution|May 29, 2024
Long-term evolution of human seasonal influenza virus A(H3N2) is associated with an increase in polymerase complex activityRené M Vigeveno, Alvin X Han, Robert P de Vries, et al.
Nature Communications|April 6, 2024
Probing altered receptor specificities of antigenically drifting human H3N2 viruses by chemoenzymatic synthesis, NMR, and modelingLuca Unione, Augustinus N A Ammerlaan, Gerlof P Bosman, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A long-chain heparan sulfate capture mechanism directs paracrine GDNF-GFRα1 signalling through RETMia I Zol-Hanlon, Beatrice Rix, Salomé Bodet-Lefèvre, et al.
Science Advances|December 22, 2021
Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfatesRichard Karlsson, Pradeep Chopra, Apoorva Joshi, et al.
Cell Host & Microbe|June 18, 2024
H19 influenza A virus exhibits species-specific MHC class II receptor usageUmut Karakus, Ignacio Mena, Jithesh Kottur, et al.
Blood Advances|July 2, 2020
Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicityA J Gerard Jansen, Thom Spaan, Hui Zhi Low, et al.
Cell Reports|June 13, 2019
N-Glycolylneuraminic Acid as a Receptor for Influenza A VirusesFrederik Broszeit, Netanel Tzarum, Xueyong Zhu, et al.
Pageof 34